Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Kocur
    Junior Member
    • Mar 2013
    • 4

    #1

    A few questions regarding RNA-seq results

    Hi,

    I am new to the forum and this is my first post:-). I have a few questions regarding RNA-seq results. Recently, we have performed an RNA-seq experiment and analysed the data using the galaxy.psu.edu server.

    1. In some cases we got strange mapping results using TopHat and hg19 full as a reference genome. Have a look at figure "Strange mapping results". As you can see, there are a lot of reads mapped to an intron. Does it happen also in your data?

    2. Im my results there are a lot of small RNAs (MIRs and SNORDs). In my opinion this is because their sequences are usually embedded within other genes, for example:
    gene name: SNORD24
    locus: chr9:136215068-136218280
    gene name: RPL7A
    locus: chr9:136215068-136218280
    Please have a look at the "Snord24 and Rpl7a" figure for details. Do you also get small RNAs in your results?
    3. The Snord24 gene is highly upregulated in control conditions, with FPKM value of 5089 (and less than 20 reads mapping to it). On the other hand, FPKM value for Rpl7a is much lower, only about 440. I know that Rpl7a is longer, but still have some doubts about the way FPKM is calculated. This is why I would like to ask you the following questions:
    (a) Do Cufflinks and Cuffdiff take the actual gene length or locus length in FPKM calculations?
    In the case of SNORD24, the actual gene length is about 70, while locus length is about 3200.
    (b) Which reads are taken into account in FPKM calculations: only those mapping to actual gene or all those mapping to a locus?

    Thanks for help in advance.
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
41 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...